M C Aumont|J F Morisson-Castagnet - JoVE Visualize

Showing results (51-60 of 55) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 55 results.

Archives Des Maladies Du Coeur Et Des Vaisseaux|October 26, 1999

[Evaluation of a specific French scale of activity in chronic heart failure. A national multicenter study. Group for Cardiac Insufficiency and Cardiomyopathy of the French Society of Cardiology]P Gibelin, M C Aumont, J F Aupetit, et al.

Radiology|November 1, 1995

Iliac artery patency before and immediately after percutaneous transluminal angioplasty: assessment with time-of-flight MR angiographyJ P Laissy, O Limot, M C Henry-Feugeas, et al.

Blood|March 27, 2001

Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery diseaseD Moatti, S Faure, F Fumeron, et al.

Clinical Pharmacology and Therapeutics|April 5, 2012

Pharmacokinetic and pharmacodynamic variability of fluindione in octogenariansE Comets, B Diquet, S Legrain, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|April 9, 1999

Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects : impact of the V264M substitution on plasma levels of TFPID Moatti, P Seknadji, C Galand, et al.

Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 55 results.

Archives Des Maladies Du Coeur Et Des Vaisseaux|October 26, 1999

[Evaluation of a specific French scale of activity in chronic heart failure. A national multicenter study. Group for Cardiac Insufficiency and Cardiomyopathy of the French Society of Cardiology]P Gibelin, M C Aumont, J F Aupetit, et al.

Radiology|November 1, 1995

Iliac artery patency before and immediately after percutaneous transluminal angioplasty: assessment with time-of-flight MR angiographyJ P Laissy, O Limot, M C Henry-Feugeas, et al.

Blood|March 27, 2001

Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery diseaseD Moatti, S Faure, F Fumeron, et al.

Clinical Pharmacology and Therapeutics|April 5, 2012

Pharmacokinetic and pharmacodynamic variability of fluindione in octogenariansE Comets, B Diquet, S Legrain, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|April 9, 1999

Polymorphisms of the tissue factor pathway inhibitor (TFPI) gene in patients with acute coronary syndromes and in healthy subjects : impact of the V264M substitution on plasma levels of TFPID Moatti, P Seknadji, C Galand, et al.

Pageof 6